- Home
- KRO vs OCUL Comparison
KRO vs OCUL Comparison
Compare KRO & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRO
- OCUL
- Stock Information
- Founded
- KRO 1916
- OCUL 2006
- Country
- KRO United States
- OCUL United States
- Employees
- KRO N/A
- OCUL N/A
- Industry
- KRO Major Chemicals
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- KRO Industrials
- OCUL Health Care
- Exchange
- KRO Nasdaq
- OCUL Nasdaq
- Market Cap
- KRO 803.0M
- OCUL 957.3M
- IPO Year
- KRO N/A
- OCUL 2014
- Fundamental
- Price
- KRO $7.70
- OCUL $7.71
- Analyst Decision
- KRO Hold
- OCUL Strong Buy
- Analyst Count
- KRO 3
- OCUL 10
- Target Price
- KRO $12.00
- OCUL $16.22
- AVG Volume (30 Days)
- KRO 300.2K
- OCUL 1.8M
- Earning Date
- KRO 05-07-2025
- OCUL 05-06-2025
- Dividend Yield
- KRO 2.60%
- OCUL N/A
- EPS Growth
- KRO N/A
- OCUL N/A
- EPS
- KRO 0.75
- OCUL N/A
- Revenue
- KRO $1,887,100,000.00
- OCUL $63,723,000.00
- Revenue This Year
- KRO $13.24
- OCUL $13.32
- Revenue Next Year
- KRO $7.35
- OCUL $13.13
- P/E Ratio
- KRO $10.25
- OCUL N/A
- Revenue Growth
- KRO 13.24
- OCUL 9.03
- 52 Week Low
- KRO $6.19
- OCUL $4.06
- 52 Week High
- KRO $14.50
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- KRO 56.38
- OCUL 54.41
- Support Level
- KRO $6.75
- OCUL $6.94
- Resistance Level
- KRO $7.22
- OCUL $8.23
- Average True Range (ATR)
- KRO 0.44
- OCUL 0.61
- MACD
- KRO 0.15
- OCUL 0.12
- Stochastic Oscillator
- KRO 97.79
- OCUL 78.60
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.